TWI250872B - Carbamate compounds for use in preventing or treating bipolar disorder - Google Patents

Carbamate compounds for use in preventing or treating bipolar disorder Download PDF

Info

Publication number
TWI250872B
TWI250872B TW091103500A TW91103500A TWI250872B TW I250872 B TWI250872 B TW I250872B TW 091103500 A TW091103500 A TW 091103500A TW 91103500 A TW91103500 A TW 91103500A TW I250872 B TWI250872 B TW I250872B
Authority
TW
Taiwan
Prior art keywords
group
formula
pharmaceutical composition
mirror image
image isomer
Prior art date
Application number
TW091103500A
Other languages
English (en)
Chinese (zh)
Inventor
Carlos R Plata-Salaman
Boyu Zhao
Roy E Twyman
Yong Moon Choi
Robert Gordon
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of TWI250872B publication Critical patent/TWI250872B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
TW091103500A 2001-02-27 2002-02-27 Carbamate compounds for use in preventing or treating bipolar disorder TWI250872B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27168101P 2001-02-27 2001-02-27
US10/081,766 US6562867B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating bipolar disorder

Publications (1)

Publication Number Publication Date
TWI250872B true TWI250872B (en) 2006-03-11

Family

ID=26765948

Family Applications (1)

Application Number Title Priority Date Filing Date
TW091103500A TWI250872B (en) 2001-02-27 2002-02-27 Carbamate compounds for use in preventing or treating bipolar disorder

Country Status (26)

Country Link
US (1) US6562867B2 (enExample)
EP (1) EP1408953B1 (enExample)
JP (1) JP4276837B2 (enExample)
KR (1) KR100946944B1 (enExample)
CN (1) CN1250215C (enExample)
AT (1) ATE324108T1 (enExample)
BR (1) BR0207644A (enExample)
CA (1) CA2439475C (enExample)
CY (1) CY1105330T1 (enExample)
CZ (1) CZ20032300A3 (enExample)
DE (1) DE60210976T2 (enExample)
DK (1) DK1408953T3 (enExample)
ES (1) ES2262801T3 (enExample)
HU (1) HUP0303243A3 (enExample)
IL (1) IL157590A0 (enExample)
MX (1) MXPA03007717A (enExample)
MY (1) MY129304A (enExample)
NO (1) NO20033802L (enExample)
NZ (1) NZ527988A (enExample)
PL (1) PL364638A1 (enExample)
PT (1) PT1408953E (enExample)
RS (1) RS50677B (enExample)
RU (1) RU2300372C2 (enExample)
TW (1) TWI250872B (enExample)
WO (1) WO2002067921A1 (enExample)
ZA (1) ZA200307465B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1250213C (zh) * 2000-07-21 2006-04-12 奥索-麦克尼尔药品公司 用于预防或治疗神经性疼痛和丛集性头痛及有或没有先兆的偏头痛的氨基甲酸酯化合物
CN1503665A (zh) * 2001-02-27 2004-06-09 ����-������ҩƷ��˾ 用于预防或治疗焦虑症的氨基甲酸酯化合物
PT1383489E (pt) * 2001-02-27 2007-06-21 Ortho Mcneil Pharm Inc Compostos carbamato para utilização na prevenção ou tratamento de distúrbios neurodegenerativos
DE60232796D1 (de) 2001-07-16 2009-08-13 Ortho Mcneil Pharm Inc Carbamate verbindungen zur vorbeugung oder behandlung von neuropathischen schmerzen
DK1809273T3 (da) * 2004-09-16 2010-08-02 Janssen Pharmaceutica Nv Anvendelse af 2-phenyl-1,2-ethandiol-(di)carbamater til behandling af epileptogenese
RU2417077C2 (ru) 2005-06-08 2011-04-27 Ск Холдингз Ко., Лтд. Способ лечения чрезмерной дневной сонливости (варианты)
US20070021501A1 (en) * 2005-07-12 2007-01-25 Twyman Roy E Methods of treating epileptogenesis
JP2010508355A (ja) * 2006-10-30 2010-03-18 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 鬱病を処置する方法
EA200970435A1 (ru) * 2006-10-31 2009-10-30 Янссен Фармацевтика, Н. В. Лечение общих расстройств развития
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
CN105189450B (zh) * 2013-03-12 2019-09-13 比皮艾思药物研发有限公司 氨基甲酸苯酯化合物及包含该化合物的用于预防或治疗精神障碍的组合物
US10195151B2 (en) 2016-09-06 2019-02-05 Jazz Pharmaceuticals International Iii Limited Formulations of (R)-2-amino-3-phenylpropyl carbamate
KR102635938B1 (ko) * 2016-12-14 2024-02-13 에스케이바이오팜 주식회사 양극성 장애의 예방, 경감 또는 치료를 위한 카바메이트 화합물의 용도
MY203401A (en) 2017-06-02 2024-06-26 Jazz Pharmaceuticals Ireland Ltd Methods and compositions for treating excessive sleepiness
US10940133B1 (en) 2020-03-19 2021-03-09 Jazz Pharmaceuticals Ireland Limited Methods of providing solriamfetol therapy to subjects with impaired renal function

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3278380A (en) * 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
HU219911B (hu) * 1994-06-16 2001-09-28 Pfizer Inc. Pirazolo-piridin-származékok, alkalmazásuk és ezeket tartalmazó gyógyászati készítmények
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

Also Published As

Publication number Publication date
YU67803A (sh) 2006-08-17
ES2262801T3 (es) 2006-12-01
WO2002067921A1 (en) 2002-09-06
RS50677B (sr) 2010-06-30
MY129304A (en) 2007-03-30
KR20030087010A (ko) 2003-11-12
EP1408953A1 (en) 2004-04-21
CZ20032300A3 (cs) 2005-01-12
CN1250215C (zh) 2006-04-12
KR100946944B1 (ko) 2010-03-15
JP2004533415A (ja) 2004-11-04
CY1105330T1 (el) 2010-03-03
NO20033802L (no) 2003-10-22
RU2003128997A (ru) 2005-03-20
IL157590A0 (en) 2004-03-28
HUP0303243A2 (hu) 2004-01-28
CN1505506A (zh) 2004-06-16
JP4276837B2 (ja) 2009-06-10
US6562867B2 (en) 2003-05-13
US20020198257A1 (en) 2002-12-26
RU2300372C2 (ru) 2007-06-10
HUP0303243A3 (en) 2012-07-30
DE60210976D1 (de) 2006-06-01
PT1408953E (pt) 2006-07-31
NO20033802D0 (no) 2003-08-26
BR0207644A (pt) 2004-03-09
MXPA03007717A (es) 2005-11-08
NZ527988A (en) 2006-01-27
ZA200307465B (en) 2005-03-17
CA2439475C (en) 2010-05-18
DK1408953T3 (da) 2006-08-21
ATE324108T1 (de) 2006-05-15
PL364638A1 (en) 2004-12-13
HK1063436A1 (en) 2004-12-31
CA2439475A1 (en) 2002-09-06
DE60210976T2 (de) 2007-05-24
EP1408953B1 (en) 2006-04-26

Similar Documents

Publication Publication Date Title
TWI250872B (en) Carbamate compounds for use in preventing or treating bipolar disorder
TWI419681B (zh) 胺基甲酸酯用於製造供治療白天過度嗜睡（eds）的藥物之用途
JP2024516421A (ja) Ｍｄｍａ鏡像異性体
HU226138B1 (en) R-enantiomer of n-propargyl-1-aminoindan, salts, compositions and uses thereof
TWI331524B (en) Carbamate compounds for use in preventing or treating movement disorders
JP7429942B2 (ja) テトラヒドロ－ｎ，ｎ－ジメチル－２，２－ジフェニル－３－フランメタンアミン（ａｎａｖｅｘ２－７３）のエナンチオマーならびにシグマ１レセプターにより調節されるアルツハイマー型および他の傷害の処置におけるその使用
JP4276839B2 (ja) 双極性障害の予防もしくは治療における使用のためのカルバメート化合物
TWI304735B (en) Carbamate compounds for use in the treatment of pain
JP6768520B2 (ja) 医療用の（ｓ）−ピルリンドールおよびその薬学的に許容可能な塩
MX2008000249A (es) Combinaciones de eszopiclona y o-desmetilvenlafaxina y metodos de tratamiento de menopausia y trastornos del estado de animo, ansiedad y cognitivos.
US20110223150A1 (en) Neutraceutical-Based Topical Anxiolytic Agent and Method of Use
EP1401424B1 (en) Carbamate compounds for use in preventing or treating psychotic disorders
JP2023506480A (ja) アルツハイマー病の治療のための化合物
AU2002242296A1 (en) Carbamate compounds for use in preventing or treating psychotic disorders
TW200418481A (en) Method of treating movement disorders using barbituric acid derivatives
US20020147206A1 (en) Combination treatment of multiple sclerosis (MS), other demyelinating conditions and peripheral neuropathy, especially painful neuropathies and diabetic neuropathy
KR102693607B1 (ko) 하지 불안 증후군을 치료하기 위한 치료제
Chen A COMPARATIVE STUDY OF EPHEDRINE, PSEUDO-EPHEDRINE AND ß-PHENYL-ETHYLAMINE: WITH REFERENCE TO THEIR EFFECTS ON THE PUPIL AND ON THE BLOOD PRESSURE
JP2009539941A (ja) Ｓｌｖ３０８およびｌ−ｄｏｐａを含んでなる組み合わせ製剤
TWI752282B (zh) 苯甲酸或其鹽及衍生物用於預防或治療憂鬱症之用途
CA2585560C (en) Use of acetyl l-carnitine for the treatment of fibromyalgic syndrome
Lehmann A new preparation for sedation in organic brain disease and senile disturbances.
WO2023215338A1 (en) Compositions and methods for treating cluster headache
JP6216913B1 (ja) 医薬組成物
JP2017088584A (ja) 医薬組成物